Resebidrag 2024 Schweiz, Swiss Nordic Bio 2024 den 7 mars

Viktiga resultat som projektet gav

The objective for the conference was to meet and engage with potential Swiss investors and pharma companies that we had not yet had any dialogue with. We had a range of productive first-hand meetings and we consider it a success that we got in touch with a segment of investors we normally don´t have access to or meet. Thus the goals prior to the conference have been met.

Långsiktiga effekter som förväntas

A range of productive first-hand meetings with potential prospective investors we had not previously met. No pharma companies of interest were participating on the day.

Upplägg och genomförande

We had a 10 minute presentation followed by lunch mingle and 1-to-1 meetings with prospective investors. The meetings were all productive and have opened new dialogues for the company.

Externa länkar

Swiss-Nordic investment and partnering meeting connecting Nordic countries with Swiss investors